GLP-1 Medications May Boost Male Fertility, Early Study Finds

Male factor contributes to more than half of the roughly 15 % of U.S. couples who experience difficulty conceiving, according to Yale Medicine. GLP-1 receptor agonists, approved for diabetes, have become widely prescribed for weight loss, prompting investigation of their reproductive effects.

CNN

A multicenter study led by Dr. Pratibha Natesh enrolled men aged 18-65 with elevated body-mass index. Participants received a GLP-1 medication for 24 weeks. Investigators reported increases in serum testosterone, total sperm count, and the proportion of normally shaped sperm.

CNN

The trial measured baseline and post-treatment hormone panels and semen analyses. After the intervention, average testosterone rose, sperm concentration improved, and morphological assessments showed a higher percentage of sperm with normal size and shape. Specific numeric values were not disclosed.

CNN

Dr. Natesh suggested the results could make GLP-1 agents a non-hormonal alternative to testosterone replacement, which often suppresses spermatogenesis. Dr. Lidia Mínguez Alarcón cautioned that the cohort comprised only high-BMI men, urging broader trials. Dr. Amin Herati warned rapid fat loss may signal reproductive suppression.

CNN

Weight loss linked to GLP-1 therapy can improve hormone function, raising testosterone and reducing inflammatory and metabolic stressors that impair sperm production. Improved semen quality has been associated with better long-term health outcomes for men.

CNN

The investigators noted the study’s restriction to obese participants limits generalizability. Dr. Mínguez Alarcón highlighted the lack of long-term safety data. Dr. Herati added that abrupt adipose loss, whether surgical or pharmacologic, can trigger hypothalamic signals that temporarily curb fertility.

CNN

Current evidence lacks data on men with lower body-mass index, dose-response relationships, and the durability of sperm improvements after discontinuing GLP-1 therapy.

CNN

• “if it’s the chicken or the egg,” — Amin Herati, urologist, Johns Hopkins Hospital

CNN

• “The research was only conducted on men with high body mass index, so it is hard to say if the rest of the population would also see benefits to their fertility, Minguez Alarcón said.” — Lidia Mínguez Alarcón, epidemiologist, Brigham and Women’s Hospital, Harvard Medical School

CNN

• “If further studies continue to show that GLP-1s are a good treatment for male infertility, the drugs could provide a better alternative to testosterone replacement therapy, which can suppress sperm production, she added.” — Pratibha Natesh, endocrinologist, University Hospitals Coventry and Warwickshire

CNN

• “Good semen quality and healthy levels of testosterone have been associated with better long-term health in men, she said.” — Lidia Mínguez Alarcón

CNN

• “A sudden change in the amount of body fat, as seen from bariatric surgery and sometimes from GLP-1 medications, may signal to the brain that it is not a safe time to reproduce and limit fertility, he added.” — Amin Herati

CNN

Future research should address men with lower body-mass index, evaluate the durability of sperm improvements after stopping GLP-1 therapy, and compare outcomes with testosterone replacement treatment.

CNN